Advisory Committees

Research, Reports, and Announcements

The U.S. Food and Drug Administration, to assist in its mission to protect and promote the public health, uses 50 committees and panels to obtain independent expert advice on scientific, technical, and policy matters. The public and Congress regularly show interest in these advisory committees (ACs), especially the screening for conflicts of interest and the use of waivers for some conflicts. Although the agency has taken a variety of steps to increase transparency and predictability of its ACs, FDA continues to seek opportunities to assess its advisory committee program for future improvement efforts.


Important messages to the public on events surrounding FDA advisory committees

Page Last Updated: 03/06/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English